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Bovine viral diarrhoea virus (BVDV) and related ruminant pestiviruses occur worldwide
and cause considerable economic losses in livestock and severely impair animal welfare.
Switzerland started a national mandatory control programme in 2008 aiming to eradicate
BVD from the Swiss cattle population. The peculiar biology of pestiviruses with the
birth of persistently infected (PI) animals upon in utero infection in addition to transient
infection of naïve animals requires vertical and horizontal transmission to be taken into
account. Initially, every animal was tested for PI within the first year, followed by testing
for the presence of virus in all newborn calves for the next four years. Prevalence of
calves being born PI thus diminished substantially from around 1.4% to <0.02%, which
enabled broad testing for the virus to be abandoned and switching to economically more
favourable serological surveillance with vaccination being prohibited. By the end of 2020,
more than 99.5% of all cattle farms in Switzerland were free of BVDV but eliminating the
last remaining PI animals turned out to be a tougher nut to crack. In this review, we
describe the Swiss BVD eradication scheme and the hurdles that were encountered and
still remain during the implementation of the programme. The main challenge is to rapidly
identify the source of infection in case of a positive result during antibody surveillance,
and to efficiently protect the cattle population from re-infection, particularly in light of
the endemic presence of the related pestivirus border disease virus (BDV) in sheep. As a
consequence of these measures, complete eradication will (hopefully) soon be achieved,
and the final step will then be the continuous documentation of freedom of disease.
Keywords: pestivirus, bovine viral diarrhoea virus, border disease virus, eradication, sheep, molecular
epidemiology, persistent infection, transient infection
PESTIVIRUSES IN THEIR HOST POPULATION
Pestiviruses have gained increased attention as several new species were discovered in recent years.
Previously, the genus Pestivirus in the family Flaviviridae comprised the four species bovine viral
diarrhoea virus (BVDV)-1 and−2, classical swine fever virus (CSFV) and border disease virus
(BDV) from sheep (1, 2). In addition, several new members termed as “atypical pestiviruses” were
not yet classified as species (3), e.g., giraffe pestivirus [(4, 5) and references therein], HoBi-like
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pestiviruses (6), Bungowannah virus (7), or a pestivirus from
pronghorn antelopes (8). Recently, a number of new pestiviruses
were described from a large variety of species, such as atypical
porcine pestivirus (APPV) (9) and Linda virus (10) in pigs,
phocoena pestivirus in harbour porpoise (11) and, outside
the order Artiodactyla, pestiviruses in rats (12), bats (13), or
pangolins (14) (Figure 1). Together with the fact that a number
of pestiviruses exhibit a broad species tropism, it became evident
that taxonomic classification of pestiviruses based on the host
species they were isolated from was not feasible anymore.
Therefore, a new nomenclature using alphabetic characters was
proposed (15), such as Pestivirus A, B, D, and H for the
widespread ruminant pestiviruses BVDV-1,−2, BDV, and HoBi-
like, respectively, that this review will concentrate on.
Viruses use two different strategies to remain in their host
population. On the one hand, the so called “hit & run” approach
indicates that a primary host is infected for only a short duration
requiring the virus to be rapidly transferred to the next host.
Rabies virus, which ultimately kills the primary, transiently
infected host, and influenza virus or the currently pandemic
SARS-CoV-2 virus, all leave behind an at least partially immune
host, and are typical examples of this approach. By contrast, the
“infect & persist” (also called “hit & stay”) strategy indicates that
the host is chronically or even lifelong infected, which mostly
requires that the virus evolved sophisticated means to evade the
host’s immune system (19, 20).Well-known examples of the latter
strategy are HCV, HIV, or herpesviruses.
The successful worldwide survival of BVDV (21) and other
ruminant pestiviruses in their host population is based on the
fact that they apply both strategies, i.e., transient and persistent
infections (22). The latter is established upon foetal infection
of pregnant cows within the first ∼150 days of gestation with
a non-cytopathic (ncp) biotype of BVDV. (i) This early time
point of foetal infection prior to the development of adaptive
immunity, (ii) the virus’ ability to block the activation of the host’s
innate antiviral response, and (iii) the distinct epitheliochorial
placentation of ruminants that does not allow the transfer
of maternal antibodies, leads to virus-specific B- and T-cell
immunotolerance and the birth of a persistently infected (PI) calf
(23, 24). They might appear healthy, but respiratory symptoms
are more common in young animals whereas enteric symptoms
are observed more often in older animals (25). In addition, the
PI calves are at risk of developing fatal Mucosal Disease (MD),
where both, a cytopathic (cp) and an ncp, biotype can be isolated.
A large variety of mutations in the viral RNA genome of the ncp
biotype, such as nucleotide substitutions or recombination with
viral or host RNAs, lead to the emergence of an antigenically
homologous cp biotype [for review, see e.g., (26–28)]. The cp
biotype of BVDV can only spread in its host in the absence
of an immune response and, therefore, it can only occur and
disseminate in PI animals that are immunotolerant to strains
that are antigenically identical to the persisting virus. Due to its
systemic spread, cp BVDV ultimately kills its PI host, and thus
represents an evolutionary dead-end for such pestivirus mutants
(26). Although epidemiologically irrelevant, the dramatic clinical
picture of MD in the last phase of BVDV infection has great
implications for animal welfare. In contrast to other persistent
viral infections such as herpesviruses, PI animals produce neither
a cellular nor a humoral immune response against the persisting
virus strain and remain, therefore, antibody negative. The PI
animals continue to shed large amounts of virus for life and
remain a constant thread to spread the virus to naïve animals and
represent the most important reservoir maintaining the virus in
its host population.
In addition to this persistence, acute infection of adult,
naïve cattle with either biotype of BVDV results in transient
viremia that is often asymptomatic or accompanied by only mild
diarrhoea or respiratory symptoms, but in rare cases, severe
thrombocytopenia and haemorrhages might be observed (29).
During acute infection lasting ∼2 weeks, virus might be found
in various secretions and, thus, might be further transmitted to
new, susceptible hosts. However, transient infections on their
own are not sufficient to sustain virus circulation for long periods
in its host, with a possible exception in large herds [(30–33), and
unpublished observation], which are rarely found in Switzerland.
Nevertheless, transient infections might well-contribute to local
transmissions bypassing the temporary absence of susceptible,
pregnant animals, finally leading to the infection of naïve,
pregnant animals, and to the re-emergence of new PI animals
that are required for the long-term survival of this virus in its
host population (23). Thus, ruminant pestiviruses are successfully
using both infection strategies, i.e., infect & persist as well as hit
& run, which has direct consequences on the implementation
of BVD control programs, e.g., interpretation of antigen- and
antibody tests, or the time span taken into account at contact
tracing, as discussed in this review.
Ruminant pestiviruses have probably circulated for hundreds
of years in their hosts (34, 35) causing large economic losses (36–
39). To reduce this financial burden, several countries, or regions
introduced control programmes to reduce or even eradicate
BVDV from the cattle population (40–50). In this review, we
portray the eradication scheme implemented in Switzerland
in 2008 describing pros and cons of the strategy chosen and
exemplify various hurdles that appeared on the way to a BVDV-
free Swiss cattle population. With >99.5% of herds being BVDV-
free, Switzerland almost achieved this goal, and the experiences
gained in the last decade might provide useful information for
veterinary authorities implementing new control programmes in
other areas.
SWISS ERADICATION SCHEME
The entire cattle population in Switzerland comprises ∼1.5–1.6
million animals, and annually, 600,000–700,00 calves are born
(34). The disease costs due to BVDV were estimated between 9
and 16 million Swiss francs per year (51, 52), depending on the
model applied and whether losses by transiently infected (TI)
animals were included. This led the various breeding associations
in Switzerland to demand eradication of BVDV from the Swiss
cattle population. The Swiss BVD control programme started
in 2008 and is based on the detection and elimination of
every PI animal (Figure 2). The control programme was divided
into three phases: (i) the initial phase when the entire cattle
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FIGURE 1 | Phylogenetic analysis and classification of pestiviruses based on the nucleotide sequence of the entire open reading frame (ORF). The evolutionary history
was inferred using the Maximum Likelihood method based on the General Time Reversible model (16), with the tree with the highest log likelihood being shown. A
discrete gamma distribution was used to model evolutionary rate differences among sites. The percentage of replicate trees in which the associated taxa clustered
together in the bootstrap test (100 replicates) are shown next to the branches (17), with only maximal values of 100 being shown. The tree is drawn to scale, with
branch lengths measured in the number of substitutions per site. The analysis involved 29 nucleotide sequences. Codon positions included were 1st + 2nd + 3rd +
non-coding. All positions with <95% site coverage were eliminated. There were a total of 9,912 positions in the final dataset. Evolutionary analyses were conducted in
MEGA7 (18). The GenBank accession numbers of the sequences used are listed in Supplementary Table 1.
population was to be ear-notched and antigen tested, except pure
fattening farms where animals only leave for slaughter, (ii) the
calf phase with antigen testing of all newborn calves, and (iii) the
surveillance phase with serological testing of disease-free herds
via bulk milk in dairy herds and blood samples in beef herds
(52–54). The latter phase meant that vaccination was prohibited
from the outset. Two important additional basic principles were
imposed that were deemed to be non-negotiable throughout the
control scheme: First, cattle movements should not be hampered
or only for a short time by testing or restrictions. This also
required a simultaneous start to the national control programme
in all cantons. Second, the case definition of an infected herd
should be exclusively based on the detection of a PI animal.
These directives would be expected to limit the economic burden
posed by the eradication measures on the individual farms,
and concomitantly, should increase the commitment of farmers
to actively participate in the programme. Retrospectively, it
might be questioned from an epidemiological viewpoint whether
the decision not to regulate animal movements might have
reduced the effectiveness of the control programme. Thus, animal
movement was shown to have great importance for BVD control
in Switzerland (55), and regulation of animal movement has
been described as an important measure in the successful control
programme in Sweden (56).
2008: Start With Virological Testing
In 2008, the whole cattle population was screened for the
presence of PI animals, starting in spring with the animals
that will spend the summer on common alpine pastures. In
this initial screening, 0.8% of all bovines were virus-positive,
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FIGURE 2 | Number of yearly BVD events between 2008 and 2020 and method of BVD surveillance. The number of BVD events (detection of one or more PI animals
in a previously BVD-free herd) (y-axis) per year (x-axis) are indicated (blue line with numbers indicated above). The surveillance mode applied in these years is
indicated: (i) population screening in 2008 followed by yearly virological testing of all newborn calves (symbol: cattle head with ear tagging); (ii) spot tests by blood
samples (symbol: cow with syringe) from living bovines sampled on farm (horizontal symbol) and mainly from slaughtered bovines (vertical symbol); (iii) bulk milk testing
(symbol: blue flagon).
and 20.0% of all herds had at least one virus positive animal
(57). Subsequently, all newborn calves were tested for BVDV,
either by antigen ELISA or by RT-PCR using ear notches,
mostly taken by the farmer, or blood samples. Since autumn
2009, epidemiological investigations including contact tracing
were required for every PI animal identified. The aim was to
decrease the prevalence of PI animals close to zero within 3
years to be able to switch to surveillance based on serology
(57, 58). Between 2008 to 2012, the proportion of all newborn
calves being PI fell from 1.4% to <0.02% (59). In 2011, the
situation was re-assessed, and it was concluded that the number
of infected herds was still too high to start monitoring by
serology. Concomitantly, the regional veterinary services were
rather reluctant to abandon the simple and proven antigen
testing scheme and to switch to the more complicated serological
surveillance. In addition, owing to the high seroprevalence before
the start of the eradication programme (60), the proportion of
positive tank milk samples was assumed to be still too high to
test the dairy herds accordingly. In addition, 55 PI animals that
initially tested negative (“false negative”) were detected through
epidemiological investigations until the end of 2010 (57), further
implying that some gaps in the control scheme needed to be
closed. Thus, the transition from virological to serological testing
was postponed to 2012.
2012: Transition to Surveillance by
Serology
In 2012, both testing schemes, i.e., testing all newborn animals
for the presence of virus and herd testing for antibodies, were
applied in parallel to gain more experience and to increase trust
in the serological surveillance keeping a high commitment by
all stakeholders to the control programme. Dairy herds were
monitored by bulk milk serology, and the non-dairy herds by
blood samples from a group of young cattle (so-called “young
animal window” or “spot test”) (61, 62). The results of the
bulk milk ELISA were categorised into 4 classes (see chapter
“Detection of Antibodies”) according to their antibody level. All
samples yielding an antibody result being categorised in class 3
and those from class 2 with an increase of the ELISA-PP value
(percentage positivity value) of 4% or more compared to the
previous test were regarded as “non-negative.” These definitions
limited the number of herds with a positive (non-negative) result
that were required to be examined by spot test. While the dairy
herds were screened twice a year, the remaining herds were
only monitored every third year, as sampling and analysing by
spot test was the biggest cost drivers in serological surveillance.
Data from 2012 indicated a lower risk of PI births in the non-
dairy sector compared to dairy herds, justifying these different
testing schemes retrospectively. Data obtained in this “transition
year” indicated that the level of seropositivity appeared to be
sufficiently low, and not least due to the high costs associated with
virological testing of all calves (37, 52), the switch to exclusive
serological surveillance was implemented in 2013 even if the PI
prevalence of all newborn calves was still at∼0.02% (23, 59).
2013–2018: Antibody Surveillance
All dairy herds should be tested twice yearly and all non-
dairy herds once every three year. The spot test should include
at least five animals not <6 months of age and born after
September 2009, or 10% of the stock in larger herds. Additional
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requirements for animals to be included in a spot test were (i)
that they were born at least 1 month after the elimination of
the last PI animal in the herd; (ii) that they stayed in the herd
to be tested for at least 6 months, (iii) that they were not part
of a herd containing a PI animal during and after its stay in
that herd, and (iv) that the animals were not previously tested
seropositive. Spot tests were also performed in dairy herds with
a “non-negative” bulk milk result. The classification of a bulk
milk test result as “non-negative” was adapted at the end of 2014,
as the interpretation of the progression of the antibody titre in
herds categorised as class 2 by the PP value between two samples
was too complex. To simplify the interpretation, all samples in
class ≥2 were defined as non-negative, despite this leading to an
increase in positive results and a higher workload for the regional
veterinary services. In the first 3 years of surveillance, samples
for spot tests were taken on the farm by the cantonal veterinary
services. This resulted in only about 80% of the non-dairy herds
being sampled at least once in the 3 years. In addition, these herds
were not tested uniformly in this period but most of them were
tested in the last year. Thus, the increase in the case count 2013–
2015 (Figure 2) could be at least partly attributed to the increased
testing in non-dairy herds toward the end of this 3-year period.
In 2015, the sampling frequency for dairy herds was reduced
to once per year, with the sampling in spring 2015 accounting
for the same year, whereas the samples taken in autumn 2015
were counted for 2016. This led to an elongated period without
testing dairy farms from autumn 2015 to autumn 2016. At the
time this decision was taken, the prevailing opinion was that
the virus had almost been eradicated, so surveillance could be
considerably reduced. Unfortunately, this turned out not to be
the case at all. The eradication scheme suffered a severe setback,
with yearly case numbers doubling from 2015 to 2017 (Figure 2).
As a consequence, epidemiological investigations were increased
in autumn 2015 (compare chapter next chapter), and the
surveillance was intensified in 2017 with testing of dairy herds
again twice per year and in 2019, testing all other herds increased
to once per year. Despite the outbreak in 2017 mainly affecting
dairy herds, it is most likely that the sharp regional rise in cases
in that year was linked to a cluster of heavily interconnected herds
and individual non-compliance with the control programme.
However, it is safe to assume that reduced surveillance certainly
contributed to the steady increase in the spread of BVD in
the years 2012–2017 (Figure 2). It was not until 2019 that
another consequence of the 2017 outbreak became apparent: the
seropositivity rate of bulk milk samples increased considerably,
as seropositive replacement heifers from herds affected by the
previous outbreak were often moved to other herds where they
come into lactation. This led again to an increase in the number
of positive bulk milk samples and consequently, the number of
spot tests required, further increasing the costs and the workload
for the regional veterinary services.
The regional veterinary services responsible for sampling on-
site estimated the workload as being too high if all non-dairy
herds were to be sampled yearly. To overcome this limitation,
the project RiBeS (“Rinderbeprobung am Schlachthof”; sampling
of cattle at the abattoir) was initiated in 2016 to take blood
samples for surveillance in cattle during meat inspection at large
abattoirs, as similarly proposed later in Japan (63). Sampling
by RiBeS was simultaneously used for additional projects, e.g.,
related to bluetongue virus, bovine herpes virus-1, or enzootic
bovine leukosis (bovine leukaemia virus). Thus, the frequency
of monitoring non-dairy herds should be increased by RiBeS
without the high workload arising by sampling on-site. But in
contrast to the assumption that blood sampling at abattoirs would
intensify monitoring of non-dairy farms, it turned out that the
coverage of the population was actually lower. One reason for this
decrease was clearly the fact that the project was still in its infancy
and blood samples could only be taken at two of the eight large-
scale slaughterhouses in 2016. This problem was solved, and
sampling at the abattoirs reached the expected level in 2017 and
even increased in 2018, enabling an increase in the surveillance
of non-dairy herds to almost a yearly interval.
A spot test is considered positive if at least one animal is
serological positive. For small herds, the size can be reduced from
five to two animals as it was sometimes impossible to find more
animals fulfilling all the requirements. In situations where only
one animal is positive, the regional veterinary services perform a
risk analysis to determine whether a suspected case is established
and whether measures should be imposed on the herd. Spot tests
in dairy herds are always taken from animals living on the farm
by a veterinarian on a single day. Since 2018, spot tests from
non-dairy herds are mostly taken during meat inspection at the
abattoirs. The two big differences compared to the sampling in
dairy herds by the classical spot test is that (i) the sampling takes
place over a prolonged period and (ii) no second sample can be
taken from the tested animals. Consequently, mistaken sample
identification or false-positive test results are more difficult to
verify. Evaluation of the results of the spot tests and the bulk
milk samples indicated that in 2018, in about 89% of the positive
screening results, no PI animal could be identified. Reasonsmight
be that the animal might already has left the herd, or the spot tests
were false-positive in both herd types. This provides evidence that
serologically positive animals are still not restricted to animals
that had contact with known PI animals. As a consequence, these
seropositive animals are a major problem for effectively targeting
the control efforts only to the herds where active transmission is
indeed occurring.
2019ff: The Endgame?
As a result of these constantly high surveillance efforts, case
numbers have dropped again from 258 infections in new herds
in 2017 to 121 in 2020 (Figure 2). Experience gained in recent
years clearly showed that (i) early reductions in surveillance and
(ii) gaps in case investigations severely jeopardise the success
of the eradication scheme. Concerning the former, surveillance
in dairy herds continued with two samplings per year, whereas
monitoring of non-dairy herds was increased considerably.
This was achieved by programming an application for mobile
phones (RiBeS-App) to identify bovines that should be sampled
at an abattoir, which enables the collection of blood samples
in almost all slaughterhouses in the country, including the
smaller facilities. This led to a marked increase in the average
percentage of non-dairy herds that were tested yearly by spot
tests (Table 1). Nevertheless, especially in smaller cantons with
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TABLE 1 | Bulk milk testing and fraction of non-dairy herds with complete spot tests per year in 2013–2020.
Year Bulk milk tests in dairy herds Spot tests completed
in non-dairy herds
Total [n] Yearly testings [n] Negative [n] Non-negative [n] Non-negative [%] [% of herds)
2013 39,503 2 (S & A) 29,276 10,227 25.89% 33.8%
2014 42,539 2 (S & A) 37,494 5,045 11.86% 31.5%
2015 20,159 1 (S) 19,314 845 4.19% 20.2%
2016 19,478 1 (A-15) 18,217 1,261 6.47% 33.3%
2017 38,714 2 (A-16 & A) 37,977 737 1.9% 14.4%
2018 36,979 2 (S & A) 36,084 895 2.42% 23.3%
2019 36,198 2 (S & A) 34,275 1,923 5.31% 80.9%
2020 35,608 2 (S & A) 34,024 1,584 4.45% n.a.
The total number of bulk milk samples taken and the number of samplings per year from dairy farms that had to be sampled according to the eradication scheme are indicated. Samples
were classified according to their ELISA PP-values as described in section Detection of Antibodies, with samples assigned to class 0 or 1 being regarded as negative, and to class 2
or 3 as non-negative. The percentage of non-dairy herds that were annually surveyed by spot tests are given, but do not represents a precise determination as no detailed data were
available. In 2013–2018, one third of all non-dairy herds were to be tested by spot tests, whereas all of them should have been tested in 2019.
S, Spring; A, autumn; A-15, autumn 2015 counting for the year 2016; A-16, autumn 2016 counting for spring 2017); n.a., data not available.
no large slaughterhouse, only about a third of all samples
required for the spot tests could be taken at the abattoirs,
requiring more elaborate, and costly blood sampling on the
farms. Overall, the number of serological tests conducted within
the surveillance scheme has doubled to 65,000 from 2016 to 2018.
In case a new PI animal is identified, detailed and timely contact
tracing is required, investigating all possible exposures retro-
and prospectively. Thus, the possibility that the same source of
infection might have “laterally” generated additional PI animals
in addition to the one detected by surveillance needs to be
considered, as well as the possibility that the newly identified PI
animal already led to the infection of other pregnant animals. The
measures for the herds with positive animals remained about the
same during the eradication programme, but the investigations
for suspected cases, for example if a spot test was positive
but no PI animal could be detected, were clearly intensified.
With the help of computerised epidemiological tracing and
targeted testing, PI animals were regularly detected earlier
than would have been the case by the serological surveillance
scheme. This is also apparent by the number of virological tests
performed during these control measures that increased 3-fold
from 2016 to 2018 to 30,000 analyses per year. This permitted the
veterinary authorities to stabilise the situation, and case counts
are decreasing since 2017.
Data Management Systems
The conceptual layout of the Swiss computerised data
management has been previously described (54). In short,
the centrepiece is the computerised information system (ISVet)
of the Swiss Veterinary Service, which provides automated
documents for both, the Veterinary Service and private
veterinarians, on all aspects relevant to veterinary public
health. Specific data and documents are accessible by different
user groups, (i) via a BVD-Web platform for practitioners,
(ii) via ISVet for the Veterinary Services and (iii) the Swiss
animal movement database (AMD) for farmers. Results from
all laboratory tests for BVD are transmitted to a centralised
laboratory database run by the Federal Food Safety and
Veterinary Office (FSVO), which is itself connected to the
data on the herds and the animals in ISVet. As IT systems
are generally not long-lived and given the long duration of
this control programme that began in 2008, a new laboratory
information system database (Alis) containing a more detailed
data structure was introduced in 2013. Similarly, ISVet was
replaced by “Asan,” but given the complexity of the ongoing
BVD control programme in ISVet and the expected costs of
transferring the whole functionality to the new application, it
was decided that ISVet should remain functional exclusively
for the BVD control programme. As a downside, the routine in
using ISVet was lost when experienced users need to be replaced
by new operators accustomed to Asan, and technical support
for ISVet was greatly reduced in the belief that it would be shut
down completely after a few years—which was obviously not
the case.
The applications RiBeS and RiBeS-App, used to indicate
which animals the meat inspectors need to sample at the
abattoirs, are completely independent from the other software
applications, but they provide an interface with the resource-
planning software of the enterprise of the large and small
abattoirs, respectively. Taking samples according to RiBeS is now
well-established in the meat inspection process. Nevertheless,
food safety clearly remains the priority in the process of meat
inspection, and the additional effort needs to be financially
compensated. To profit from possible synergisms, a more
integrated system from management to integration of laboratory
results for all cattle surveillance programmes is planned in
the future. A more detailed data structure would be of great
value especially for the spot tests, as with the current systems,
differentiation of the results of the spot test from the ones of other
serological assays in dairy herds proved to be difficult.
In the last 3 years, the use of a data warehouse combining
information from different sources allowed the production of
useful reports for epidemiological investigations and contact
tracing of animals and herds with positive results in serological
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surveillance. These possibilities are increasingly used by the
regional veterinary services. The format of flexible reports
combining the information from the AMD, the laboratory
database, ISVet, and RiBeS proved to be an important
improvement. The animal movement database is the most
important source for tracing of animals, and current efforts are
directed toward specifically transforming data available from
the AMD into information useful for BVD control, such as the
calculation of calving periods and the proportion of twins and
stillbirths per herd. The data management systems used offer
great flexibility, but as a disadvantage, retrospective evaluations
are rather difficult as the previous status of animals and herds are
not available, e.g., in contrast to data management systems used
in Germany (64).
VIRUS TRANSMISSION
As virus is shed from all secretions, e.g., saliva, semen, tears,
milk, and to a lesser extent faeces, direct contact of susceptible
animals to persistently or transiently infected cattle is the most
prominent way of horizontal transmission. Summer grazing on
one of the 6,740 communal alpine pastures (as of 2019) is very
common in Switzerland (65), with approximately one third of all
cattle being moved to these pastures every year (55). This offers
ample opportunity for direct contact of animals from different
farms and, therefore, for the virus being transferred to different
premises (66–72). As the virus can retain its infectivity for several
hours or even days depending on the environmental conditions
(73), spread by indirect contact through contaminated surfaces,
fomites, equipment, vehicles, personnel, and even veterinarians
cannot be excluded. Contaminated biological products such
as semen or vaccines and even airborne transmission were
reported to be possible routes of transmission [(49, 74, 75)
and references therein]. As examples, BVDV transmission was
reported from external contamination of rubber membranes of
vaccine vials that were punctured by the syringe (76), from orf
vaccines for sheep that were contaminated with BVDV-2 (77),
from contaminated transport vehicles (78, 79), or by airborne
transmission via short distances of maximally 10m from pens
harbouring a PI animal (76, 80).
Transmission From PI and TI Animals
As PI animals constantly shed large amounts of viruses during
their whole lifetime, transmission from these animals is highly
effective. This is exemplified by the facts that a within-herd
seroprevalence of at least 60–70% is highly indicative for the
presence of a PI animal (60), and that the presence of a PI calf
for only 1 h was sufficient to infect the contact animals (81). Thus,
the basic reproductive number (R0), which indicates the expected
number of new infections generated by one case in a completely
susceptible herd, might be well above 30 for the transmission by
PI animals (75). This is in accordance with the model that PI
animals are the most important reservoir for BVDV to remain
in the population.
Viremia in transiently infected (TI) animals starts at around
2–3 days post-infection (p.i.), and last up to 1–2 weeks until
seroconversion of the infected host occurs. This indicates that the
presence of infectious virus in secretions from acutely infected
animals can be expected. Indeed, infectious virus could be
isolated from nasal swabs from 5 out of 6 experimentally infected
animals between day 5 and 10 p.i. (82), whereas this could be
extended up to 21 days p.i. by treatment of the animals with
dexamethasone (83). Similarly, 10 calves infected intranasally all
seroconverted within 15-36 days p.i., and BVDV could be isolated
from some of these animals between day 5 and 8 (84). In another
study, animals were acutely infected by contact to a PI animal,
but no infectious virus could be isolated from nasal swabs of
these contact animals despite positive detection of viral RNA by
RT-PCR in blood and nasal swabs starting at 6–21 days p.i. and
lasting for 1–9 days (85). It is worth noting that detection of
virus in serum or nasal swabs by RT-PCR depends on the dose
of virus used to infect the animals (83), and can be detected
up to ∼100 days p.i. despite interim seroconversion (83, 86).
However, virus isolation in cell culture indicative of the presence
of infectious virus was not successful at the late time points.
Interestingly, blood transfusion with blood at day 98 p.i. from
acutely infected animals to naïve cattle led to seroconversion of
the latter, indicating that virus in the blood still retains infectivity
despite being unable to be transmitted naturally to sentinel
animals (86).
This rather short time window of virus secretion together with
a reduced amount of virus shed by acutely infected compared
to PI animals leads to strongly reduced efficiency of virus
transmission. Thus, none of the 14 sentinel animals were infected
by nose-to-nose contact with 5 TI calves (87). This was confirmed
in another study by the same group where 8 calves exposed to
10 TI animals were not infected despite the detection of BVDV
in nasal swabs in 6 out of 10 of the TI animals, whereas a
bovine coronavirus was readily transmitted to all the animals
(84). The infectious dose leading to a transient infection (83),
the virulence of the virus strain involved (32), or concomitant
infections, e.g., within the bovine respiratory disease complex
(74), might further influence the efficiency of virus transmission
from TI cattle, but data are rather scarce. A summary of studies
that investigated transmission from TI animals is collected in
Supplementary Table 2.
Transmission via Semen
In rare cases, the persistence of BVDV in testicles of postpubertal
bulls was described despite these bulls seroconverting after
transient infection and being free of virus in serum thereafter.
In these animals, infectious virus could be detected in semen
for months (88–91), even though the viral load in semen from
TI animals were considerably lower than in semen from PI
bulls (92). Thus, pestivirus transmission by artificial insemination
with semen from TI bulls could be observed, but secondary
transmission cycles were only rarely described (88). Similar
results were reported using semen from PI bulls, but despite
high rate of seroconversion of the inseminated heifers (93–95),
no (95) or only two PI animals (93) were generated out of 5
and 61 inseminated heifers, respectively. Therefore, transmission
of ruminant pestiviruses via semen does occur, but the rate of
production of PI calves and even less, further transmission to
naïve animals, is remarkably low.
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Risk Assessment for Transmission From TI
Animals
As BVD eradication in cattle was not achieved as quickly as
expected and the source of infection could not be identified in
several cases, doubts were raised that the focus on PI animals
as the main source of infection could not be justified. Anecdotal
accounts of transmission that appeared to have occurred through
TI animals raised concerns that this route of transmission might
be more common and jeopardise the control programme, and
a risk assessment was appreciated by the local authorities and
veterinarians. Overall, direct transmission from PI animals to
naïve cattle remains the most prominent way of spreading
ruminant pestiviruses (96, 97). As they shed virus throughout
their life, PI animals of any age are effective transmitters (a few
examples are summarised in Supplementary Table 3), with the
possible exception of temporarily reduced viral shedding after
intake of colostrum containing maternal neutralising antibodies
(74, 98). There appears to be a consensus that the risk of
transmission by TI animals is negligible and mostly unable
to sustain a chain of infection for an extended time period
(49). Indirectly, this is corroborated as all BVDV eradication
programmes were successful provided they aimed at the
elimination of PI animals (45). Calculations of the reproductive
number R0 were rarely done, and the results were quite diverse,
but in most cases, R0 for TI animals was below 1. Thus, R0
was reported to be around 0.25 for BVDV-1 and−2 being
transmitted by experimentally generated TI animals, whereas the
introduction of PI animal led to an unlimited increase of R0
[“R0 = ∞” (96)]. In accordance with this very high R0 in the
presence of a PI animal, herd immunity would need to be close
to 100% to achieve full protection, which is not realistic (99).
By contrast, a previous study done in the Netherlands reported
an R0 of ∼3.3 in a herd that did not contain a PI animal (30).
However, PI animals were at least temporarily on the premise in
different pens, and the chain of infection ceased before infection
of all naïve cattle, indicating that R0 might nevertheless have
been below 1 for transient transmissions only. Surprisingly, the
within-herd transmission was rather slow in the presence of a PI
animal, with an R0 of only 3.9 reported in his study (30). In a
mathematical model, R0 was calculated to be 2.3 in the absence
of a PI animal but was increased by an order of magnitude by the
introduction of a PI calf (100).
Summarising these studies (Supplementary Table 2),
transmission from TI cattle to contact animals at physiological
conditions occurred in only 3 out of 60 cases, with additional
transmission only in the case of immunosuppressed calves
(83). Out of this, an R0 of 0.05 (95% CI; 0.01–0.14) can be
estimated. Of course, herd size, cattle management, general
health status etc. will influence the efficiency of transmission,
but TI animals appear to be an even smaller risk than surface
or fomite contamination by secretions of PI animals, especially
during the birth of PI animals. Therefore, the detection of
TI animals is not the main risk factor to maintain a chain of
infection, but rather represents an important indicator of the
presence of a source of infection, e.g., a PI calf. In later stages of
BVDV eradication with a highly susceptible cattle population
and intense surveillance, transient infections might nevertheless
be observed and might lead to either costly investigations or, in
rare cases, to the transmission to a pregnant heifer and the birth
of new PI calf.
DIAGNOSTICS
Since the first description of BVDV in 1946 (101, 102), a
number of methods were developed to directly identify the virus
or its components, and indirectly to monitor seroconversions
as signs of infection. Diagnostic tests are applied either to
diagnose clinical cases, or to survey groups of animals to
determine the (sero-) prevalence of infection. In the case of a
BVD eradication programme, the latter clearly applies, as most
acute and persistent infections are inapparent, and the ultimate
goal is to identify every PI individual. The special biology of
ruminant pestiviruses as described in the first chapter, with
acute infections characterised by transient viremia followed by
seroconversion, and the presence of immunotolerant PI animals,
requires the application of various diagnostic assays and detailed
interpretation of their results. In addition, possible interference
by maternal antibodies imposes the selection of different tests
depending on the age of and the type of sample taken from the
animal. A large body of literature is available on diagnostics tests,
but in the following paragraph, we concentrate on the assays
used in Switzerland during the BVD eradication scheme and
discuss pitfalls observed in this “large field experiment”. Thus, we
apologise that we are only able to cite a small number of articles
which by no means detract from the effort made by many labs to
improve diagnostics of this important livestock disease.
Detection of Antibodies
For detection of antibodies, serum neutralisation test (SNT) is
highly sensitive, and was and still is the gold standard, but the
requirement of cell cultures limits its use to more specialised
laboratories. Thus, agar gel immunodiffusion test and enzyme-
linked immunosorbent assay (ELISA) were rather routinely
applied (103, 104), with the former not being used in Switzerland
compared to, e.g., Australia or New Zealand (105). Today, a
number of indirect and blocking ELISAs to detect antibodies to
ruminant pestiviruses are commercially available that can be used
with various sample materials such as serum, plasma, or milk.
Most of these ELISA tests use the non-structural protein NS3
(p80) as capture antigen as this is the most conserved pestivirus
antigen, with fewer assays detecting antibodies to the structural
protein Erns (106, 107). By contrast, neutralising antibodies are
primarily directed against the envelope glycoprotein E2, which
at least partially explains discordant results that were reported
between antibody ELISA and SNT (108).
In countries where HoBi-like pestiviruses (Pestivirus H) are
circulating, specific assays need to be developed as the test
routinely applied for BVDV and BDV appear to unreliably
detect these types of antibodies (109–112). Independent of the
type of ELISA used, none are currently able to differentiate
BVDV antibodies from BDV. Correctly attributing antibodies
to one of the species requires cross-neutralisation assays using
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different virus strains as challenge virus. This type of assay needs
to be adjusted to the corresponding epidemiological situation,
i.e., to the individual types of viruses circulating in a given
area. Currently, using two strains of BVDV-1, one that is
and one that is not circulating in Switzerland, and one local
BDV strain, enables at least 80% of all sera to be designated
to one of the two ruminant pestiviruses [(108), and Huser
et al., in revision]. Requiring cell cultures and three separate
SNTs for cross-neutralisation, this test is rather elaborate, time
consuming and costly and, thus, is performed exclusively by our
reference laboratory and only upon request of the corresponding
veterinary authority.
Detection of new antibody-positive animals or a rise in
the level of antibodies in bulk milk during the surveillance
phase is indicative of the presence of a PI animal in a herd.
As a result, investigation at the farm level with analysis of
every individual animal in the herd is required. Cows shortly
around calving are also tested in such cases, yielding sometimes
negative results in antibody ELISA despite records indicating
that the animal was previously tested antibody positive. This
might be explained by the fact that cows around parturition
actively transfer enormous amounts of antibodies of the IgG1
subtype from serum into the mammary gland, thereby assuring
colostrum-mediated protection of the newborns. Depending
on the antibody ELISA used, this drop in antibody levels in
the serum of the cow might lead to a negative result around
parturition (113, 114) and, therefore, it is not recommended to
perform antibody ELISAs∼2 weeks before and after calving. This
effect is not specific to BVDV antibodies, as IgG1 antibodies in
general are transported into the milk as, amongst others, was
reported for antibodies to Coxiella burnetii in addition to BVDV
(113, 114).
Every laboratory that offers BVDV diagnostics in Switzerland
needs to be accredited, and every test applied in these laboratories
requires approval by the federal authorities. Switzerland is a
federalistic country and, therefore, the implementation of the
national eradication programme is organised by the 23 different
cantons, with possible collaborations between some of the
cantonal veterinary services. Accordingly, every canton is free
to choose a laboratory for its analysis, and each accredited
laboratory is free to choose which test to use as long as the
test was approved. All these ELISA tests were reported to
have sensitivities and specificities above 90% using serum as
sample material (106, 115–118), with somewhat lower values
using milk samples (117). Despite these similar characteristics
for the different tests, it appeared that the performance varied
between different regions using various ELISAs. This was also
recently confirmed where various commercially available ELISA
tests generated false negative results, especially in samples with
low antibody titres according to a neutralisation test (119).
However, it must be kept in mind that it is not only the
test that is responsible for inaccurate results. Correct labelling
of the sample, quality of the sample material, duration of
and temperature during shipment and correct handling during
analysis all contribute to the final result. In such a field situation,
no test can be 100% accurate, and the occurrence of false-positive
or negative results cannot be completely avoided. To reduce
this variability, the analysis for antibodies in bulk milk during
the surveillance phase in recent years, i.e., toward the end of
the eradication programme, is performed by a single laboratory
for the whole country. Bulk milk samples are collected twice
monthly for quality control of commercial milk (milk testing)
from all dairy herds, and such samples are used twice a year for
BVD monitoring during a defined collection period. The bulk
milk samples are analysed using the SVANOVIR R© BVDV-Ab
ELISA from Svanova (now Indical Bioscience). Based on their
PP values (percentage positivity value), farms are assigned to one
of four classes defined by the test manufacturer according to the
Swedish national programme (120), i.e., class 0 (PP < 3%), class
1 (PP ≥ 3% and < 14%), class 2 (PP ≥ 14% and < 30%), and
class 3 (PP ≥ 30%). Nevertheless, analysing the sample by one
laboratory only does not eliminate all pitfalls, as with the analysis
of bulk milk samples in spring and fall each year, an inexplicable
rise in antibody titre could be observed in some farms, without
detection of a PI animal following investigation of all animals in
the herd (unpublished observation). At least in some cases, the
purchase of an antibody-positive cow could be identified as the
cause of the rise in bulk milk antibodies, or the new animal was
even the only seropositive animal in the herd, with the bulk milk
antibody level returning to background level after drying off of
this seropositive cow. Thus, a single animal with a high antibody
level in milk can unfavourably influence antibody surveillance by
bulk milk analysis.
Currently, every blood sample that tested positive or
indeterminate by an external laboratory must be transferred to
our reference laboratory for confirmation. If the sample yields
discordant results with an indirect and, if necessary, an additional
competitive antibody ELISA, the final analysis will be done using
SNT. If no neutralising antibodies are detected in the sample,
the result will be reported as negative. Expensive and time-
consuming cross-SNT is currently the only way to differentiate
antibodies from BVDV to BDV, and is solely performed by the
reference laboratory. In addition, inappropriately re-sampling
animals only a few days after the initial test in response to
farmer’s request for a definitive result, and testing animals in
the periparturient period, are additional drawbacks regularly
encountered with antibody testing.
Detection of Viral Antigen and Viral RNA
For the direct detection of virus, virus isolation has been
considered the gold standard for many decades and is the only
test able to detect infectious virus (104, 121). Similar to the
SNT for the detection of antibodies, it is time consuming and
costly, and it requires laboratories capable of performing cell
cultures. In addition, the method is sensitive to the presence of
antibodies, e.g., maternal antibodies from colostrum intake in
young calves (122, 123), and the sensitivity is highly dependent
on the cell type used, with bovine turbinate cells being up to
two orders of magnitudes more sensitive to infection by BVDV
than the commonly used MDBK cell line [(115) and unpublished
observation]. But as “all that glitters is not gold,” it is rather RT-
PCR than virus isolation that is nowadays accepted as the most
sensitive assay (see below). For the detection of viral antigens,
immunofluorescence and immunohistochemistry was initially
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the method of choice, but antigen ELISAs replaced these assays in
routine diagnostics (104, 106, 115, 124–126). The non-structural
protein NS3 was the most common antigen detected by these
ELISAs, yielding the most sensitive results when using buffy coat
as sample material. Accordingly, flow cytometry was used in
some specialised laboratories to detect intracellular NS3, which
also enabled the identification of the cell type infected (127, 128),
but this was never routinely applied in Switzerland. In addition
to NS3, ELISAs detecting Erns in serum were commercialised,
which enables the use of serum to detect the soluble form of
this envelope glycoprotein (129, 130). Similar to virus isolation,
the antigen ELISA might yield false-negative results due to the
presence of maternal antibodies (70, 122, 123). With a half-life of
∼20–30 days, passively acquired antibodies largely wane within
two to four months (122, 131). Interestingly, maternal antibodies
directed against the viral envelope glycoproteins Erns and E2
decline at a faster rate in PI animals compared to naïve calves,
whereas antibodies to NS3 wane at around equal rates in PI
and non-infected animals [(122) and unpublished observation].
This probably reflects the presence or not of the corresponding
antigen in the serum. Including a certain “safety margin”, antigen
ELISA is therefore only used in animals older than 6 months.
These days, RT-PCR and real-time RT-PCR detecting viral
RNA are themethods of choice next to the antigen ELISA that are
routinely used to demonstrate an infection with pestiviruses (107,
118, 132–134). A wide variety of sample material can be used,
such as blood, saliva, ear notches, milk, or different material from
abortions, provided appropriate methods for RNA isolation are
established for each of the sample types. It is worth mentioning
that material from the afterbirth might test negative by RT-
PCR despite the birth of a PI animal after transient infections
of its dam, which might relate to the fact that the foetal rather
than the maternal side of the placenta is virus positive (135),
albeit more studies are required to confirm this observation.
For diagnostic purposes, the 5′-untranslated region (5′-UTR)
is usually chosen as PCR target as it is the most conserved
region in pestiviruses, enabling the simultaneous detection of
various genotypes. Accordingly, the—in the meantime famous—
“Vilcek pan-pesti primers” are sometimes still in use (136),
albeit adapted primers were designed covering the many new
pestivirus isolates identified in recent time. Nevertheless, all the
varying pestiviruses cannot be detected using a single PCR and
depending on the epidemiological situation and the species to
be investigated, specific primer/probes need to be designed. In
Switzerland, only BVDV-1 and BDV were identified in livestock
and wild ruminants to date by using a broadly specific RT-PCR
for sequencing using a mix of different forward primers (79) that
enables the detection of a variety of pestiviruses, e.g., pestiviruses,
A, B, D, and H.
As RT-PCR is largely unaffected by the presence of maternal
antibodies, it is always used with samples from animals younger
than 6 months of age. Due to its high sensitivity, RT-PCR
allows pooling of samples (137, 138) followed by re-analysis
of individual samples exclusively from positive pools. With a
prevalence of PI animals of roughly 1-2%, this considerably
reduces the costs of large-scale investigations. Based on the lower
sensitivity, it is not recommended to use the antigen ELISA test
with pooled samples (107, 139). In addition, the high sensitivity
of RT-PCR not only allows efficient detection of PI animals, but
transient infections might also provide a positive result when the
animal was sampled during the viremic phase. In general, the
viral load in PI calves is higher than during the short viremia
found in TI animals, resulting in lower Ct values in real-time RT-
PCR in PI compared to TI animals. Despite this difference being
highly significant on a population level (140), it cannot be applied
to differentiate PI from TI animals in individual cases. Thus, the
Ct values vary widely, as we observed samples from PI animals
providing Ct values above 35 or TI animals showing Ct values
lower than 20 [(33) and unpublished observation]. Re-sampling
the animal at least 3 weeks later resolves the issue in most
cases, as the viremic phase in TI animals is usually rather short-
lived. However, infections of neonates or very young calves with
BVDV might result in a prolongation of viremia due to either
an inefficient immune response in young animals (Figure 3A)
or by the inhibition of the calf ’s immune response by immune
complexes of the virus with antibodies obtained by colostrum
intake (Figure 3B). In the latter case, even immunohistochemical
staining in ear notch biopsies stained positive for pestiviral
antigen (unpublished observation), despite this method being
supposed to exclusively detect PI animals (141). Thus, the results
of RT-PCR assays of a single test and even together with the
results of a paired sample taken at a later time point, needs
to be interpreted in relation to the epidemiological context of
the animal, results from other animals or the seroprevalence
in the herd, in order to obtain a definitive conclusion and to
take the appropriate measures. Finally, it has to be noted that
it is not possible to identify PI animals already in utero, at least
not with routine methods (142). Pregnant cattle carrying a PI
foetus (metaphorically called “Trojan cows”) mount a strong
humoral immune response, with neutralising titres being much
higher than in transiently infected naïve animals (143, 144). This
difference, however, is only significant in the last 1–2 months
of pregnancy and is not commonly amenable for diagnostic
purposes at the level of individual animals. Consequently, intake
of maternal antibodies by the PI animal taking colostrum from
its own mother is substantial and one should be aware of
their possible interference with the various diagnostic tests as
discussed above.
In summary, antigen ELISA and real-time RT-PCR are
the methods routinely used in Switzerland during the BVD
eradication programme, and both tests exhibit an excellent
performance. However, no test can perform at 100% sensitivity
and specificity in field situations, a fact that tends to be neglected
by a number of stakeholders. As only BVDV-1 and BDV strains
are circulating in domestic and wild ruminants in Switzerland
(34, 79, 146, 147), the pestivirus diversity is currently not an
issue for the diagnostic methods used to detect the presence
of pestiviruses. Nevertheless, BVDV-2 or HoBi-like pestiviruses,
which probably represent the greatest risk of being introduced
into the Swiss cattle population, can be identified by the methods
currently applied. The major pitfalls in antigen detection are (i)
that, especially in young calves, viremia might persist for several
weeks to months at a low level, making differentiation of TI and
PI animals rather difficult, and (ii) that re-sampling of initially
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FIGURE 3 | Course of the level of pestivirus antibodies and viral RNA in the
blood of newborn calves. Relative optical density (OD) in the ELISA for
pestivirus antibody in sera of two calves taken between day 17 and 86 (A) and
day 9 and 191 (B) of age expressed as a percentage to the OD of a standard
serum (y-axes to the left in red). Relative OD values > 30% (grey line) are
defined as positive. The presence of viral RNA by real-time RT-PCR, and the
Ct values are indicated (y-axes to the right in blue). The calf in (A) did not
receive pestivirus antibody-containing colostrum, whereas the calf in (B)
ingested maternal antibodies to BDV. The virus detected by RT-PCR could be
identified as BVDV-1b [A; (79)] and BDswiss [B; (145)], respectively.
positive animals occurs too fast, sometimes within 1 week, which
makes it more or less impossible to follow the course of infection.
SMALL AND WILD RUMINANTS
Ruminant pestiviruses are not strictly species specific and thus,
infection from small ruminants such as sheep and goats were
described in the field as well as under experimental conditions.
The presence of BDV in cattle was already discussed in a
recent review (145) and, therefore, only aspects relevant for
BVD eradication are covered here. Commingling of cattle with
persistently infected sheep led to seroconversion, reduced fertility
and abortions in pregnant animals (148–150). The declining
seroprevalence during the eradication leads to a completely
susceptible Swiss cattle population, and there were concerns that
the generation of cattle PI with BDV will strongly increase.
However, within almost 10,000 nucleotide sequences obtained
from virus isolates taken from PI (and possibly some TI) animals
since the start of the eradication programme, not a single case
of BVDV-2 and <30 animals PI with BDV were identified [(79);
Huser et al., in revision]. Interestingly, most of these PI animals
were detected in Central and Eastern Switzerland, probably
reflecting different management practises of keeping cattle and
sheep on the same premises or pastures in various regions in
Switzerland, including communal alpine pastures in summer
(67, 68, 70, 72). This is corroborated by the observation that cases
of malignant catarrhal fever in cattle, a disease caused by ovine
herpesvirus-2 with sheep representing symptomless carriers, are
similarly concentrated in Central and Eastern Switzerland (Huser
et al., in revision).
Due to cross-reactivity of antibodies to pestiviruses,
serological surveillance of BVD by ELISA does not distinguish
between BVD- and BD-virus as the source of infection. In a
recent study using an optimised SNT protocol, we could show
that <10% of pestivirus antibody ELISA-positive sera from
cattle were due to BDV infection (108). The samples were taken
between 2012 and 2014, and there was a trend for an increased
BDV seroprevalence in these samples from 4.2 to 8.1%, which
might reflect the increased susceptibility of the cattle population.
Epidemiological analysis revealed that common housing of cattle
and small ruminants, especially sheep, was the most significant
risk factor for BDV infection in cattle. Goats appear to be less
of an issue as PI goats appear to be rarely generated and their
viability is mostly severely reduced (151). As observed for the
presence of cattle PI with BDV, the highest BDV-seroprevalence
in cattle was found in Central Switzerland.
These data indicate that sheep might represent a reservoir
for ruminant pestiviruses, but their transmission to cattle occurs
only sporadically and largely depends on herd management.
Direct contact between these two species represents the highest
risk for transmission but contact between cattle and sheep
on neighbouring pastures and insufficiently cleaned trailers
commonly used by a cattle and sheep farmer could be identified
as sources of infection (79). However, as routine antibody
surveillance by ELISA does not discriminate between antibodies
to BVDV and BDV, the suspicion of BDV in sheep being the
source of infection can only be raised based on indirect evidence.
Thus, the following observations were reported that might
indicate that BDV was introduced into a farm: (i) seropositive
results in bulk milk or in the spot test of young calves that are
inexplicable as no PI animal could be found in the herd; (ii)
possible direct or indirect contact to small ruminants; (iii) only
a few seropositive animals could be identified; (iv) the values in
the antibody ELISA of the sera of seropositive animals are only
weakly positive; or (v) the ELISA results of bulk milk analysis was
low or even negative despite the presence of lactating seropositive
animals in the herd. The latter two observations might be
explained by the fact that the ELISA OD (optical density) values
of BDV antibodies appear to be generally lower than the ones
measured by BVDV antibodies (unpublished observation). But
even in case where BDV is suspected to have been introduced
into a cattle herd, the same enforcements as applied for BVDV
should be immediately taken, as in-depth analysis to differentiate
the pestiviruses takes time, whereas further transmission should
be stopped as quickly as possible.
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Previous studies showed that the pestivirus seroprevalence in
sheep was around 15–20% (152–154). Identification of the type
of pestivirus infection in sheep, if determined at all, showed a
considerable proportion of BVDV-induced antibodies, albeit 30–
60% of the samples could not be allocated at that time. Hence, it
could be envisaged that the elimination of BVDV from the cattle
population would decrease the transfer of BVDV from cattle to
sheep and thereby altering the epidemiology of pestiviruses in
small ruminants. Indeed, analysing sheep sera collected in the
Canton of Schwyz in Central Switzerland ∼7–10 years prior to
and after the start of the BVD eradication in cattle revealed
that the proportion of antibodies to BVDV compared to BDV
decreased from 13.3 to 3.5% between the early and late sampling
period (Huser et al., in revision). This provides strong evidence
that there is not only cross-species transmission of BDV from
sheep to cattle, but also significant transmission of BVDV from
cattle to sheep and, therefore, BVD eradication in cattle is also
of benefit for the sheep, despite BDV remaining endemic in the
sheep population.
In addition to small ruminants, a number of wild animals
were found to have been infected by ruminant pestiviruses [for
reviews, see (155–158)]. However, evidence for independent
virus circulation within the wild animal population without
the involvement of livestock was rarely found with possible
exceptions in chamois in the Pyrenees in France and Spain and
white-tailed deer in North America (159, 160). In Switzerland,
roe deer, red deer, chamois or ibex were considered to be virus
reservoir for pestiviruses, thereby representing a potential risk
factor for BVDV eradication in cattle. However, none of the roe
deer analysed, and only, 2.7, 2.1, and 1.8% of red deer, chamois,
and ibex, respectively, were seropositive (146) out of a total of
1,877 samples analysed. Differentiation of approximately half
of the seropositive samples indicated that the majority of wild
ruminant sera contained antibody to BDV rather than BVDV
(147). This might be corroborated by the observations that
using RT-PCR, only one single serum from a chamois contained
viral RNA that could be typed as BVDV-1 h (146), the most
prominent genotype found in cattle in Switzerland (34). These
data indicate that wild ruminants in Switzerland do not represent
a pestivirus reservoir but are rather an incidentally spill-over host
and, therefore, do not pose a risk to BVD eradication in cattle. A
similar conclusion was made when looking at wild and domestic
ruminants in Southern Spain (161).
Overall, these data strongly suggest that small and wild
ruminants in Switzerland are not a significant risk factor
for BVD eradication in cattle. However, occasional spill-
over transmission might occur from cattle to small and wild
ruminants and vice versa, the latter mostly during alpine
farming in summer. As the surveillance programme is based
on the seronegativity of cattle herds, every transmission event
detected during transmission requires further investigations to
elicit the possible source of infection. Legally, this implies
that infection of cattle with other ruminant pestiviruses such
BDV (Pestivirus D) or HoBi-like viruses (Pestivirus H, never
observed in Switzerland and, thus, not further discussed here),
are not specified by the animal disease regulation (animal
disease ordinance; “Tierseuchenverordnung TSV”). As routinely
applied diagnostic tests do not differentiate between BVDV and
BDV, any positive result is defined as a positive case with all
its consequences defined in the TSV for BVDV. However, if
antibody monitoring or further investigations on virus-positive
cattle indicate that, e.g., a PI animal is infected with BDV,
the TSV does not apply, and any further actions rely only
on a general act regulating animal disease control measures
in the animal disease law (“Tierseuchengesetz TSG”). In light
of new pestiviruses that were recently described and might
be discovered in future, a broader definition for pestivirus
infection in cattle might be advantageous and legally assured
in an animal disease regulation in countries with scheduled
or ongoing eradication programmes. Similar problems were
faced with the eradication of caprine arthritis encephalitis virus
(CAEV) in Swiss goats, where sheep infected with Visna-Maedi
virus (VMV) or CAEV play a significant role as a reservoir
for such small ruminant lentiviruses (SRLV) and, therefore,
as a risk factor in the control of CAEV in the Swiss goat
population (162–166).
MOLECULAR EPIDEMIOLOGY
As stated above (chapter Data management systems), the
enormous logistical tasks encountered in the eradication
programme could not have been achieved without appropriate
data management systems, including the animal movement
database (AMD) (54). In the AMD, every single bovine
animal with its unique ear tag number can be identified,
incl. information such as date and place of birth, additional
farm-related data, information on its animal parents, animal
movement, slaughter or death, etc. As with any database,
inaccurate or missing entries (167), either by negligence or
fraudulence, should be avoided, as this might severely limit
the practicality of the database. In addition to its role in the
logistics of the testing scheme, this digital data system is also an
invaluable tool used for contact tracing, an important instrument
in classical epidemiology to identify a possible source of infection
and further contact animals. In addition to the “classical” tools,
molecular epidemiology is nowadays an important method in
disease control (168–170). Accordingly, molecular epidemiology
was successfully used in pestivirus control and surveillance, e.g.,
for CSFV (171–173) and various BVDV control schemes ins
Scandinavia (45, 56, 174), the UK (175), Austria (78), Germany
(176, 177) and Scotland (178). In Switzerland, we sequenced
a short stretch of ∼240 bp of the BVDV genome in the 5′-
UTR from a large number of PI animals and combined this
information with data from the AMD (34, 79). Initially, this
sequencing effort intended to identify animals PI with BDV, but
it was soon realised that these sequences are a great opportunity
to be used in molecular epidemiology. On the one hand, we
could gain an overview on the BVD viral strains circulating
in Switzerland, which is important to control for possible
introductions of new variants into the country and tomonitor the
suitability of current diagnostics tools. Next to a few PI animals
infected with BDV as discussed above, we exclusively found
BVDV-1 strains of the subgenotype BVDV-1b, −1e, 1h, and−1k
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with the exception of two isolates of the 1g and 1l subgenotype
(34). Notably, we never found an animal PI with BVDV-2 or
HoBi-like pestiviruses, despite these genotypes being described in
neighbouring countries, i.e., BVDV-II in France, Germany, and
Italy (177, 179–181), and HoBi-like viruses in Italy (182). On the
other hand, we were able to support the cantonal authorities in
tracking chains of infection, e.g., whether several PI animals in a
single farm or on a single pasture originated from one or more
virus introductions, or whether repeated births of PI animals on
the same farm were caused by consecutive infections over time
originating from the same source of infection or represented new
virus introductions (79).
The very strict and ambitious BVDV eradication in
Switzerland led to a quick initial success [Figure 2; (59)].
Since then, the eradication remains, however, somewhat in a
stalemate. This notwithstanding, the good news prevails with
more than 99.5% of all cattle farms being free of BVDV at the
beginning of 2021. To obtain complete freedom from BVDV, it
is of upmost importance to identify and remove the remaining
PI animals as quickly as possible. This might be exemplified
by the observations that a change in personal within cantonal
authorities might have led to a temporal surge in the number
of PI animals produced, as case investigations could not be
followed in time with the rigour required. Similarly, the fact
that the oldest PI animals from which we received a blood
sample for sequencing in the surveillance phase was between
1 and 3.5 years of age—with an outlier in 2015 at an age of 7.3
years (Table 2)—indicates that a number of PI animals were
clearly identified too late, giving them enough time to further
transmit the virus, possibly also to naïve pregnant animals.
Out of ∼10,000 animals imported annually, only a handful of
these adult animals were tested positive, and a few sequences
might have been obtained from TI animals, indicating that the
majority of the sample sequences were indeed from PI animals
infected in Switzerland. Thus, some of these older animals
must either have been missed in the surveillance scheme, or
they were previously tested false negative. And these are not
only single cases that were detected exceptionally late, but
around 10% of all samples from PI animals we received for
sequencing were from animals of 6 months of age or older
(Table 2).
Currently, there appears to be around 10 chains of infection
remaining, with some of them circulating for several years. The
largest cluster we observed, i.e., isolates with identical sequences
in the short stretch of the 5′-UTR, contains samples from around
1,000 animals collected since 2011. With pestiviruses being RNA
viruses with a considerable mutation rate, it is, however, not
plausible that all these isolates represent identical viruses, albeit
a common origin cannot be excluded. Thus, the rather low
resolution in the 5′-UTR is clearly sufficient to allocate the
sequences to a specific (sub-)genotype, but it is insufficient to
differentiate individual virus isolates. To enhance the resolution
in sequencing to be of help for molecular epidemiology, we
established a pilot scheme where we sequenced fragments
of 800–1,000 nucleotides in length of selected clusters with
identical sequences in the 5′-UTR by classical Sanger sequencing.
This study confirmed that BVD viral strains can be further
differentiated using these larger fragments, as exemplified in
Figure 4. This differentiation requires the analysis of regions
much more heterogeneous than the 5′-UTR, which made it
unfeasible to design a single PCR-primer pair for all virus
strains. This will clearly increase the costs, despite using well-
established, cost-effective Sanger sequencing. In addition, data
editing and interpretation are much more elaborate, which
will considerably increase hands-on time required for analysis.
Currently, this extended analysis cannot be performed on
a routine basis in Switzerland with the available resources.
Nonetheless, it might be a helpful tool in selected cases to support
the identification of a possible source of infection, or in the
final stages of the eradication programme as similarly applied
in Sweden (183) or Austria (78). However, this requires that
samples from every PI animal identified nationwide are available
for sequencing. But independent of the fact that molecular
epidemiology is a useful mean in the identification of a source
of infection, the crucial point in the eradication is and remains
the factor “time,” i.e., the pace at which the source of infection
can be identified and eliminated before the virus can further
be transmitted.
SUMMARY AND OUTLOOK
Based on the rather high number of BVD antibody positive
animals prior to 2008 (60), Switzerland decided to take a
rather radical approach in testing all cattle within <1 year
without prior testing of the herd seroprevalence, as was done
in the Scandinavian counties (56). Together with the notion
that vaccines were extremely rarely used in Switzerland, it
was intended from the beginning that surveillance after initial
testing for virus will be done by serology and, therefore,
vaccination was prohibited from the start of the eradication
scheme. Testing for virus in all newborn calves was performed
until the end of 2012, when <0.02% of all calves born were
PI, an impressive reduction in just 5 years after having started
at roughly 1.4% in 2018 (59). By the end of 2020, 99.6% of
all herds were declared BVD free, with only 42 herds out of
∼34,000 farms housing cattle in the country (with ∼43,000
farms in 2008 at the start of the eradication programme) and
105 farms with individual animals being locked, the latter
being pregnant animals that might have been infected during
pregnancy (“Trojan cows”). Such Trojan cows present a great
risk for re-introduction of BVDV into previously naïve herds
(119), and strict control of such animals is absolutely required.
Overall, the following measures were most relevant to achieve
eradication of BVDV in Swiss cattle: (i) Testing all animals
in the first year to massively reduce the risk of infection, (ii)
testing newborn calves within 5 days after birth and prompt
elimination of PI animals, (iii) risk-based constraints on animal
movement, (iv) nationwide uniform strategy including the ban
on vaccination, (v) centrally organised data management, (vi)
rigorous contact tracing of all PI animals identified, and (vi)
last but not least, regular information and communication to
all stakeholders to maintain high levels of motivation to achieve
these goals.
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TABLE 2 | Age of the PI animal when it was sampled and sent to the reference laboratory for sequencing.
Year n Min [d] Max [d] Average [d] Median [d] > 180 d > 180 d [%]
2008 4,001 10 3,525 378.4 236 2,258 56.4%
2009 1,945 3 3,282 79.3 26 126 6.5%
2010 958 0 1,570 80.6 20 63 6.6%
2011 460 1 1,502 66.6 16 21 4.6%
2012 108 3 934 40.7 18 3 2.8%
2013 75 5 1,285 77.8 18 6 8.0%
2014 98 2 1,112 100.3 26 15 15.3%
2015 219 1 2,661 100.1 18 25 11.4%
2016 295 0 952 61.2 14 26 8.8%
2017 473 1 1,245 90.3 33 71 15.0%
2018 321 1 609 81.8 32 40 12.5%
2019 252 1 970 61.4 12 22 8.7%
2020 203 2 1,039 81.0 13 25 12.3%
2021* 32 7 368 67.4 44 3 9.4%
The year of sampling and the number of animals analysed is indicated, with the age (always given in days [d]) of the youngest (min) and the oldest (max) animal in addition to the mean
and medium ages of all animals tested per year is provided. The number of animals that were older than 6 months at the time of sampling are given in absolute [d] and relative [%]
numbers per year of sampling.
*Data collected by the reference laboratory until Feb 9th, 2021.
Initially, it was assumed that it would take around 10 years for
eradication to be completed, as was described for other countries
(44). However, this assumption was obviously somewhat too
optimistic as especially the final stages appear to be the crux
of the eradication programme, and the current costs for the
programme are higher than previously projected (52). In the last
seven years, always more than 98.5% of the farms have already
been BVD free, with a maximum of 99.8% at the end of 2014,
but identifying and eliminating the last PI animals is the largest
hurdle. The surveillance by serology is generally able to identify
clusters of infection, but the time until the source of infection
is finally identified and eliminated is probably too slow. The
approach to trace all contacts of PI animals to identify and test
animals at risk of infection proved to be not sufficiently effective
to replace the surveillance of the complete population for virus by
partial surveillance using antibody testing. Nevertheless, a high
proportion of PI animals and even Trojan cows were identified
by contact tracing very rapidly, indicating that a rigorous contact
tracing is extremely useful to reduce the risk of infection. A final
effort should now be taken to eradicate the virus from the few
remaining farms applying a rather strict regime. This might be
unfavourable for the few farms affected, but it would be of great
benefit for the rest of the country, as some of these herds have
continuing infection cycles over several years and regularly pose
a risk of infection risk for all their contacts.
For the final achievement of BVD eradication in Switzerland,
the following factors and measures are important for the
programme to be successful, most of them already being
in place:
- Consistent completion of the animal movement database by
every user without any gaps, possibly applying more severe
consequences for fraudulent entries.
- Continued strict application of biosecurity measures, incl.
cattle trade and summer pasturing.
- Enhanced biosecurity measures and strict supervision and
surveillance during calving of possible “Trojan dams”.
- Nationwide standardised procedure following positive results
in antibody surveillance to achieve faster response across
cantonal borders.
- Immediate start of investigations upon a positive result
through antibody surveillance, if appropriate with
coordination across cantonal borders. During these
assessments, the role of transient infections and the fact
that no test is 100% sensitive and specific must be taken
into consideration.
- Shorten the time interval between active surveillance on the
“farms of concern,” i.e., the few farms repetitively harbouring
PI animals in recent years.
- Transfer of every virus positive sample to the reference
laboratory for sequencing. Molecular epidemiology is a great
tool to track chains of infection, but this is only of help if all
sequence data are available nationwide.
- Separation of cattle and sheep. Where this is not feasible,
voluntary sanitation of the sheep population concerned
should be envisioned to avoid costly investigations over and
over again.
The aforementioned measures should enable the identification
if any remaining source of infection as quickly as possible,
and to reduce the risk of further transmission of the virus
to naïve pregnant animals within this time interval. A final,
more rigorous effort for a rather short time might be
required to achieve the final aim of eradicating BVDV from
the cattle population in Switzerland. Nevertheless, even after
successful completion of this task, continued surveillance needs
Frontiers in Veterinary Science | www.frontiersin.org 14 September 2021 | Volume 8 | Article 702730
Schweizer et al. BVD Eradication in Swiss Cattle
FIGURE 4 | Phylogenetic analysis of an alleged infection chain analysing samples with identical sequences in the 5-UTR. Fragments of 978 bp in the NS2-3 region of
the viral genome were sequenced and are shown in a phylogenetic tree. Each circle represents one single sequence from a PI animal sampled between May 2015
and February 2019, with different colours per canton representing the place of birth of the PI animal. The most antecedent sample within this cluster is indicated. The
evolutionary history was inferred by using the Maximum Likelihood method based on the Kimura 2-parameter model (184), and the tree with the highest log likelihood
is shown. A discrete gamma distribution was used to model evolutionary rate differences among sites. The tree is drawn to scale, with branch lengths measured in the
number of substitutions per site. There are maximally 11 nucleotide difference between these samples (median = 5). The analysis involved 214 nucleotide sequences.
Codon positions included were 1st + 2nd + 3rd + non-coding. There were a total of 927 positions in the final dataset. Evolutionary analyses were conducted in
MEGA7 (18). The nucleotide sequences used were submitted to GenBank, accession no. MW936384—MW936597.
to be implemented (i) as ruminant pestiviruses might be
re-introduced into the highly susceptible cattle population,
e.g., by animal import or contaminated semen or vaccines,
and (ii) as pestiviruses remain endemic in small ruminants
in Switzerland, mainly in sheep, and pose a constant risk
for re-introduction. This surveillance scheme will also be a
necessity for federal and European regulations to continuously
report the freedom of disease (185), which will hopefully soon
be achieved.
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